ABSTRACT
INTRODUCTION
Medullary thyroid carcinoma (MTC), a neuroendocrine tumor arising from parafollicular C-cells of 1 MTCs may be either sporadic or herediendocrine neoplasia (MEN) 2 syndrome: MEN2A, 2 Sporadic forms 3,4 5 MEN2A and MEN2B syndromes have distinctive phenotypes and autosomal dominant inheritance and are due to RET [3] [4] [5] The most common abnormalities that can occur in MEN2A patients are pheochromocytomas (in 40-6,7 MEN2B subjects have no observable 4 The presence of cutaneous lichen amyloidosis, pruritic plaques located on the upper back, is also reported in some kindreds with MEN2A or FMTC, 7 as well as Hirschsprung's 8 FMTC is also an autosomal dominant condition due to genetic alterations in the RET -gressive features 9 and is the most common form of 4 We present a patient with multiple endocrine and non-endocrine neoplasias-including MTC-which are not correlated and cannot be included in any of Genetic analyses revealed the presence of two 'de novo' germline mutations, one in the adenomatous polyposis coli (APC) gene and the other in the RAS Protein Activator Like 1 (RASAL1) gene as well as one somatic mutation in the RET gene, which however
CASE PRESENTATION
A 57-year-old female was followed for bilateral submitted to total thyroidectomy as well as lymph nodes excision (7/17 positive) of the left cervical was extended with diffuse infiltration of both thyroid lobes and the paratracheal fat tissue (stage, T3m-Pre-operative serum calcitonin levels were high at She presented to the outpatient endocrinology clinic history included acute myeloid leuchemia (AML) diagnosed at the age of 41 years old and treated with chemotherapy (she had received initially two cycles of idarubicine/cytarabine with complete regressionhowever, she developed Sweet syndrome-and two cycles of floudarabin and cytarabine); since September history was also marked by a surgical exeresis of a peritoneal mesothelium at the age of 43 years old the age of 53 years old for which she has constant from polyglandular autoimmune syndrome type 3 (PASIIIc) including Hashimoto's thyroiditis, autoimmune gastritis, alopecia universalis and relapsing perichondritis of the ear, while recently rheumatoid
METHODS

Genetic screening for RET gene variant
A peripheral blood sample was drawn in EDTA for molecular investigations after informed consent from peripheral blood leucocytes according to commercially available protocols (QIAGEN, Valencia, regions in the following exons: 5, 8, 10, 11, 13, 14, 15, previously found to contain activating missense RET mutations related to MTC, were amplified by polymerase chain reaction (PCR) and analyzed by classical bidirectional Sanger sequencing using BigDye Given this result, DNA was then extracted from paraffin-embedded thyroid tissue and DNA fragments encompassing all exons of the RET gene were amplified by PCR, while direct sequencing of the purified fragment was performed using BigDye Terminator
RESULTS
No mutation in the aforementioned exons of the RET -( ) was detected of the non-polar hydrophobic amino acid proline by -Further genetic analyses of blood samples, including SNP microarrays (comparative genomic hybridization; CGH) and WES (whole exome sequencing), were
Genetic analyses with CGH and WES
APC gene (R), a positively charged hydrophilic amino acid, by in exon 16 of the RASAL1 RASAL1 mutation, which leads to the amino acid replacement of arginine (R) by histidine
In silico analysis
Two sites of prediction of the functional effects of gene polymorphism were used: Polyphen (http:// ), and SIFT (http://
In silico APC mutation predicts that this variant is probably damaging to the in silico characterization RASAL1 mutation is inconsistence in its predictions as to whether or not the variant is
Immunochemistry
Paraffin-embedded tissues from MTC were stained for APC and RASAL1 protein expression (Figures 2, -ing for APC protein, whereas staining for RASAL1 
DISCUSSION
Herein, we report two novel germline mutations detected in the APC and RASAL1 genes, identified through WES, in a patient presenting with multiple neoplasias such as MTC, AML, peritoneal mesothelioma and meningioma; we also found a somatic missense RET Neither the germline heterozygous variants in the APC gene nor the RASAL1 gene have been reported APC mutation has not been described as either pathogenic or benign in people of European or Africo-American origin participating in the NHLBI exome sequencing project, while the RASAL1 mutation was already described in the gnomAD database, with a frequency Rare somatic variants have been reported in individuals with hepatoblastoma and gastric cancer strongly positive in the MTC tissue with characteristic cytoplasmic localization; it could be hypothesized that the presence of this mutation could abolish the entrance of APC into the nucleus, keeping it mainly RASAL1 gene encodes the RAS GTP-ase which serves as an inhibitory regulator of the Ras-cyclic AMK pathway that is expressed in a limited number of tissues, with the highest expression in the adult brain, thyroid gland and adrenal gland 13 Follicular variant papillary thyroid cancer presents a higher frequency among individuals with RASAL1
13 Therefore, germline RASAL1 variants may be relatively frequent in patients with apparently sporadic thyroid carcinoma 13 The R538H variant is a conservative amino acid substitution which is not likely to impact secondary protein structures as these occurs at a position that it is not conserved among
In silico Thus this variant was interpreted as being of uncertain significance and could be related to the thyroid cancer RASAL1 staining in the tissue
The somatic variant in the RET detected in the co-existence of multiple neoplasias without common histological and embryological origin in this patient cannot be included in a specific genetic pattern or clinical syndrome according to the existing data in the this patient already diagnosed with AML and treated with chemotherapy as it is known that prior exposure to chemotherapy can result in various types of somatic RASAL1 gene is very highly expressed in thyroid cells since the thyroid along with the brain and adrenal glands are the sites of -mutation or even germ mutation, thus predisposing to [14] [15] [16] Interestingly, there are some rare cases reporting occurrence of papillary thyroid cancer and meningioma in patients treated for acute lymphocytic leukemia or some years after bone mar-17,18
CONCLUSION
Patients with 'mixed or atypical' phenotypes often in these cases is difficult because there is no specific with multiple neoplasias including MTC which are not correlated and cannot be included in any known the patient presents two new germline mutations 'de novo', one in the adenomatous polyposis coli (APC) gene and the other in the RAS Protein Activator Like 1 gene as well as one somatic mutation in the RET gene, which however have never before APC and RASAL1 genes are probably involved in thyroid cancer development, along with the somatic mutation in the RET meningioma are likely related to mutations in the APC variants of uncertain significance and they have not
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